|
KIAA0528 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6304735339645E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.10134124042816E-12 |
| Normal-vs-Stage2 |
2.10189999999555E-05 |
| Normal-vs-Stage3 |
1.2179146580138E-13 |
| Normal-vs-Stage4 |
1.2116974090759E-11 |
| Stage1-vs-Stage2 |
2.552600E-01 |
| Stage1-vs-Stage3 |
2.520200E-02 |
| Stage1-vs-Stage4 |
1.094180E-01 |
| Stage2-vs-Stage3 |
1.599730E-02 |
| Stage2-vs-Stage4 |
3.235600E-02 |
| Stage3-vs-Stage4 |
8.912400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.88498130835069E-15 |
| Normal-vs-AfricanAmerican |
2.39829999999497E-05 |
| Normal-vs-Asian |
5.01609975778194E-10 |
| Caucasian-vs-AfricanAmerican |
4.937200E-01 |
| Caucasian-vs-Asian |
5.937800E-01 |
| AfricanAmerican-vs-Asian |
7.207400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.39808173319034E-14 |
| Normal-vs-Female |
2.08821848701746E-12 |
| Male-vs-Female |
3.542600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.57219792740193E-11 |
| Normal-vs-Age(41-60Yrs) |
1.65970015508776E-10 |
| Normal-vs-Age(61-80Yrs) |
1.63868918434673E-12 |
| Normal-vs-Age(81-100Yrs) |
7.62579999999957E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.252400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.396600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.157400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.224400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.137400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.643200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.88475999999271E-05 |
| Classical-VS-Follicular |
1.567200E-01 |
| Classical-VS-Other |
7.729600E-01 |
| Classical-VS-Normal |
1.70918834641043E-12 |
| Tall-VS-Follicular |
4.20540000001246E-06 |
| Tall-VS-Other |
2.472800E-01 |
| Tall-VS-Normal |
2.77555756156289E-15 |
| Follicular-VS-Other |
4.981400E-01 |
| Follicular-VS-Normal |
2.70300000004831E-06 |
| Other-VS-Normal |
3.119200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.31599953157036E-10 |
| Normal-vs-N1 |
2.78888023785839E-13 |
| N0-vs-N1 |
2.252100E-02 |
|
|
